Summary
GMR (T/R)
1.0553
90% CI Lower
0.9865
90% CI Upper
1.1289
CV Intra (%)
19.4%
Per-Subject Data
| subject | sequence | reference | test | ratio | log_diff |
|---|---|---|---|---|---|
| 1 | RT | 78.0922 | 93.5413 | 1.1978 | 0.1805 |
| 2 | RT | 91.2154 | 91.2485 | 1.0004 | 0.0004 |
| 3 | RT | 137.9859 | 183.6608 | 1.3310 | 0.2859 |
| 4 | RT | 104.9689 | 134.0253 | 1.2768 | 0.2444 |
| 5 | RT | 125.8673 | 140.2338 | 1.1141 | 0.1081 |
| 6 | RT | 115.5203 | 119.1077 | 1.0311 | 0.0306 |
| 7 | RT | 85.2897 | 81.7168 | 0.9581 | -0.0428 |
| 8 | RT | 114.5096 | 92.2194 | 0.8053 | -0.2165 |
| 9 | RT | 92.3902 | 121.6108 | 1.3163 | 0.2748 |
| 10 | RT | 92.2565 | 61.5422 | 0.6671 | -0.4048 |
| 11 | RT | 102.4589 | 98.0023 | 0.9565 | -0.0445 |
| 12 | RT | 68.2848 | 72.6841 | 1.0644 | 0.0624 |
| 13 | TR | 134.7218 | 164.8023 | 1.2233 | 0.2015 |
| 14 | TR | 84.5546 | 123.8770 | 1.4651 | 0.3819 |
| 15 | TR | 128.4112 | 161.3315 | 1.2564 | 0.2282 |
| 16 | TR | 103.4668 | 100.5349 | 0.9717 | -0.0287 |
| 17 | TR | 146.6690 | 174.7511 | 1.1915 | 0.1752 |
| 18 | TR | 84.7900 | 67.8580 | 0.8003 | -0.2228 |
| 19 | TR | 92.5012 | 126.8199 | 1.3710 | 0.3155 |
| 20 | TR | 108.8110 | 108.6222 | 0.9983 | -0.0017 |
| 21 | TR | 57.5873 | 51.8373 | 0.9002 | -0.1052 |
| 22 | TR | 122.9958 | 111.4858 | 0.9064 | -0.0983 |
| 23 | TR | 147.0213 | 149.5849 | 1.0174 | 0.0173 |
| 24 | TR | 132.5383 | 126.2007 | 0.9522 | -0.0490 |
This report was generated using OpenPKFlow -- an open-source Python workflow for pharmacometric analysis. Final regulatory interpretation should be reviewed by qualified formulation, pharmacokinetic, and regulatory experts.